Lisata Therapeutics, Inc. (LSTA)
Last updated: 2026-10-21 14:56:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Lisata Therapeutics, Inc. (LSTA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.04, with a market capitalization of $10.80M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.96 to $5.07. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$10.80M | |
$1.05 | |
$9.38 | |
$0.96 | |
$1.04 | |
24.25K | |
304.01K | |
-- | |
$5.07 | |
$0.96 | |
-- | |
-- |
Lisata Therapeutics, Inc. (LSTA) Stock Price Today
Lisata Therapeutics, Inc. (LSTA) is currently trading at $1.04 as of 2026-10-21 14:55:00, up 0.10% ($0.00) from the previous close of $1.04
During today's regular trading session, LSTA has traded between $0.96 and $9.38, with a trading volume of 24.25K shares. The current price is near the lower end of today's range.
Lisata Therapeutics, Inc. (LSTA) 7-Day Stock Price Change
Over the past seven days, Lisata Therapeutics, Inc. (LSTA) moved from $1.05 to $1.04, representing a decline of 0.86% ($0.01).
The stock traded between $0.96 and $1.15 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 97.73 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
LSTA 52-Week Price Position
Position in Range: 2.0%
LSTA is currently trading at $1.04, placing it 2.0% of the way from its 52-week low of $0.96 to its 52-week high of $5.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Lisata Therapeutics, Inc. (LSTA)?
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Lisata Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 21 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Lisata Therapeutics, Inc. (LSTA) Stock on MEXC
Eligible investors can buy real shares of Lisata Therapeutics, Inc. (LSTA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Lisata Therapeutics, Inc. (LSTA) stock price today?
2.Is LSTA stock going up or down today?
3.What is LSTA pre-market price?
4.What is LSTA after-hours price?
5.Is LSTA stock trading now?
6.Where does LSTA sit relative to its 52-week high and low?
7.What sector is Lisata Therapeutics, Inc. in?
8.What is Lisata Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is LSTA valued in terms of P/E ratio and EPS?
10.Does Lisata Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
LSTA Stock Calculator
Estimate the value between LSTA shares and USD.
LSTA Shares to USD
1.00 LSTA shares = 1.041 USD
Calculations are estimates based on the latest available price and are for reference only.



